(Q40838459)

English

Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7. (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

0 references

0 references

0 references

6

object named as

Wilschut J

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

author name string

Daemen T

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Pries F

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Bungener L

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Kraak M

4

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Regts J

5

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

publication date

1 November 2000

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

1859-1866

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Viruses in human cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

Association of human papillomavirus types 16 and 18 E6 proteins with p53.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

The human papillomavirus E6/E7 genes induce discordant changes in the expression of cell growth regulatory proteins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

Interactions of the human papillomavirus E7 protein with cell cycle regulators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

High Frequency of Latent and Clinical Human Papillomavirus Cervical Infections in Immunocompromised Human Immunodeficiency Virus-Infected Women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

Cytotoxic T lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

Human papillomavirus 16 E7 protein is associated with the nuclear matrix

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

The E7 protein of human papillomavirus (HPV) type 16 expressed by recombinant vaccinia virus can be used for detection of antibodies in sera from cervical cancer patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

A General Purification Protocol for E7 Proteins from “High- and Low-Risk” Human Papillomavirus Types Expressed in the YeastSchizosaccharomyces pombe

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

Characterization of the interactions of human papillomavirus type 16 E6 with p53 and E6-associated protein in insect and human cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

Death mechanisms in cultured cells infected by Semliki Forest virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

A new foreign policy: MHC class I molecules monitor the outside world

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

Help for cytotoxic-T-cell responses is mediated by CD40 signalling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

Immunology. Licence to kill

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

The short arm of chromosome 11 likely is involved in the regulation of the human papillomavirus type 16 early enhancer-promoter and in the suppression of the transforming activity of the viral DNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

21 January 2018

Both conserved region 1 (CR1) and CR2 of the human papillomavirus type 16 E7 oncogene are required for induction of epidermal hyperplasia and tumor formation in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro mutagenesis of a full-length cDNA clone of Semliki Forest virus: the small 6,000-molecular-weight membrane protein modulates virus release

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

7 January 2021

based on heuristic

inferred from DOI database lookup

The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

7 January 2021

based on heuristic

inferred from DOI database lookup

Two-helper RNA system for production of recombinant Semliki forest virus particles.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301257

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3301257

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40838459&oldid=2204027552"